Want to see MRAI full AI Analyst Report?
MRAI Stock Chart & Stats
$2.25
-$0.13(-5.49%)
At close: 4:00 PM EDT
$2.25
-$0.13(-5.49%)
Day’s Range― - ―
52-Week Range$0.22 - $4.16
Previous CloseN/A
Volume67.54K
Average Volume (3M)35.52K
Market Cap
$84.94M
Enterprise Value$25.73M
Total Cash (Recent Filing)$138.00K
Total Debt (Recent Filing)$662.00K
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding26,829,834
10 Day Avg. Volume14,535
30 Day Avg. Volume35,520
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.34
Price to Sales (P/S)0.61
P/FCF Ratio-1.47
Enterprise Value/Market Cap0.30
Enterprise Value/Revenue1.55
Enterprise Value/Gross Profit6.07
Enterprise Value/Ebitda-1.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring TPA Revenue ModelMarpai’s TPA model is built around recurring fees for core health-plan administration, eligibility, claims support, and member service. Contracted employer relationships can provide a repeatable revenue base and support operating leverage if the company retains clients and expands value-added services.
New Growth CapitalThe $12 million preferred financing provides additional resources to support Marpai’s healthcare services platform and growth initiatives. This can improve near-term financial flexibility and help sustain operations while management works to scale the business and pursue employer and partner opportunities.
Narrowing LossesAlthough Marpai remains unprofitable, the reduction in absolute losses is a constructive direction in operating performance. If maintained, lower losses could slow capital consumption, improve financial resilience, and create a more credible path toward eventual break-even as the platform scales.
Bears Say
Revenue Contraction And Weak MarginsDeclining revenue combined with nearly breakeven gross profit indicates that Marpai has not yet established sufficient scale or margin structure to support its cost base. Persistent weakness could limit reinvestment, reduce operating leverage, and make profitability dependent on a substantial business improvement.
Deeply Negative EquityDeeply negative equity reflects accumulated losses and leaves Marpai with limited balance-sheet flexibility. The declining asset base further reduces financial capacity, making it harder to absorb setbacks or fund expansion internally and increasing dependence on financing and successful execution.
Persistent Cash BurnConsistently negative operating and free cash flow means Marpai is not currently self-funding its operations. Continued cash burn can require additional financing, creating dilution or refinancing risk and leaving less flexibility to invest in growth unless profitability improves materially.
Marpai News
MRAI FAQ
What was Marpai’s price range in the past 12 months?
Marpai lowest stock price was $0.21 and its highest was $4.16 in the past 12 months.
What is Marpai’s market cap?
Marpai’s market cap is $84.94M.
When is Marpai’s upcoming earnings report date?
Marpai’s upcoming earnings report date is Nov 16, 2026 which is in 23 days.
How were Marpai’s earnings last quarter?
Marpai released its earnings results on Aug 13, 2026. The company reported -$0.177 earnings per share for the quarter.
Is Marpai overvalued?
According to Wall Street analysts Marpai’s price is currently Overvalued.
Does Marpai pay dividends?
Marpai does not currently pay dividends.
What is Marpai’s EPS estimate?
Marpai’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marpai have?
Marpai has 26,829,834 shares outstanding.
What happened to Marpai’s price movement after its last earnings report?
Marpai reported an EPS of -$0.177 in its last earnings report. Following the earnings report the stock price went up 0.913%.
Which hedge fund is a major shareholder of Marpai?
Currently, no hedge funds are holding shares in MRAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Marpai Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
109.60%
12-Months-Change
Fundamentals
Return on Equity
48.23%
Trailing 12-Months
Asset Growth
-14.41%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Marpai
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Technical Analysis
Ownership Overview
48.23% Insiders
0.08% Other Institutional Investors
51.69% Public Companies and
Individual Investors